[
  {
    "ts": null,
    "headline": "Why Hims & Hers Health Stock (HIMS) Is Too Hot to Handle",
    "summary": "Hims & Hers Health (HIMS) has captured significant market attention in 2025 with its dramatic stock swings, starting the year around $25, soaring above $70, dipping back near $25, and now rebounding past $52. Despite the volatility, the stock is up over 120% year-to-date, ranking it among the best-performing mid- to large-cap names, with a market valuation exceeding $13 billion. So, what’s behind this massive surge in value? Hims’ unmatched ability to capitalize on the booming demand for GLP-1 d",
    "url": "https://finnhub.io/api/news?id=67b4d039a56dfe50566c3780dfc4e275ae2ca215112a7a977d1532c9c5d71da3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748109900,
      "headline": "Why Hims & Hers Health Stock (HIMS) Is Too Hot to Handle",
      "id": 134715844,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Hims & Hers Health (HIMS) has captured significant market attention in 2025 with its dramatic stock swings, starting the year around $25, soaring above $70, dipping back near $25, and now rebounding past $52. Despite the volatility, the stock is up over 120% year-to-date, ranking it among the best-performing mid- to large-cap names, with a market valuation exceeding $13 billion. So, what’s behind this massive surge in value? Hims’ unmatched ability to capitalize on the booming demand for GLP-1 d",
      "url": "https://finnhub.io/api/news?id=67b4d039a56dfe50566c3780dfc4e275ae2ca215112a7a977d1532c9c5d71da3"
    }
  }
]